The didactic activity is happening through the course of three years of study and consists of teaching general pharmacology, pharmacology of devices and systems and pharmacotherapy notions. In this educational process the accent is on the correlation of the data regarding drugs' mechanisms of action with the therapeutic indications and of the pharmacokinetics aspects taking into consideration that these influence the dosage of the active substances. Also, during the lectures the focus is on the interactions between drugs, drugs and food and drugs and nutritive supplement.

In the process of postgraduate training are proposed courses that aims for the actualization of the informations in the field of drugs, the accent being placed on the newly authorized molecules, on the biological therapy and on the data of pharmacovigilance of older molecules.

The scientific research was made in close colaboration with different disciplines of the Faculties of Pharmacy in Bucharest or in other cities in the country and with other institutions along with which we have participated in research projects: The National Insitute of  Chimico-Pharmaceutic development, Faculty of Veterinary Medicine, Faculty of Biology. The research directions of the discipline are:

• Preclinical researches about the variability of the pharmacologic answer in analgezia tests, with three subdirectories:
  • Variability of the pharmacologic response depending on the psychoneuroendocrine typology
  • Variability of the pharmacologic response in neuropathic pain
  • Variability of the response to pain through the administration of newly synthetized organic compounds or of the active principles of vegetal nature
• Preclinical researches regarding the variability of the pharmacologic response in tests that investigate the action of psychotropic substances
• Experimental pharmacologic researches regarding the efficiency of the newly synthesized substances or of the active principles of vegetal nature in diabetes mellitus and dyslipidemia
• Experimental pharmacokinetics researches regarding the estimation of the pharmacokinetic profile of some compounds of inorganic nature
• Pharmacologic and toxicologic screening for determining the pharmacodynamic parameters of interest (place of action, latency of the effect, duration of the action) and of the acute toxicity (expressed through DL50) for newly synthesized organic substances or for active principles of vegetal nature.

There were created and validated 5 experimental pharmacologic models, that were later used in the achievement of researches of some projects and PhD theses:

• The model for inducing depression with reserpine in the mouse, starting from the idea that depression as a phenomenon is very hard to quantify in laboratory animals, in the absence of verbal scales. We used as a pharmacologic agent reserpine that produces cathecolamine depletion at the central level and can induce from a biochemical point of view a depressive syndrome at the animal.
• The experimental model of inducing hyperexcitability and manifestations of psychotic type through administration of selegiline and levodopa. These substances raise semnificantly the cerebral concentration of dopamine, with the apartion of a syndrome of psychotic type. The model can be used for testing antipsychotic substances that have an antidopaminergic mechanism.
• Experimental model for inducing aloxanic diabtes at the mouse, identifying the dose that produces an optimum response when it comes to the percentage of animals from the community at which the diabetes installs, and also the rate of survival of diabetic animals, without suplimentary administration of insulin.
• Experimental model for inducing rheumatoidic poliarthritis with Freund adjuvant to the mouse, on which we could evidentiate the positive radiologic modifications of the metotrexate conditioned under a liposome form, with a reduced systemic toxicity.
• Experimental model for inducing neuropathic pain through administering paclitaxel to the mouse, which permitted the attainment of an intense and durable hyperalgic response (maintained for approximately 3 weeks after interrupting the chimiotherapic). The animal model permitted the evaluation of the antialgic effect of some active substances administered alone or in association.
• Experimental model for hypersensibilization to contact at mice BALB/c, using as an alergen 2,4-dinitrofluorobenzene (DNFB). The alergic phenomenon was evaluated thorugh determining the thickness of the left ear with the help of a digital micrometer. This method permitted the determination of the   DE₅₀ of some hydro-alcoholic dried extracts, with the property of reducing the reaction of hypersensibilization.